Data Show MRD in Nearly Half of Ovarian Cancer Population in Remission
August 04, 2025
Further studying the biology of minimal residual disease may uncover ovarian cancer vulnerabilities and inform more effective therapies.
Author: Russ Conroy
Fact checked by:Β Roman Fabbricatore
UPDATES ANDΒ NEWS
How scientists found a weakness in one of the deadliest βundruggableβ cancers | The Washington Post
Radical Collaboration: A Cancer Funder Seeks to Solve the Problem of Siloed Research | Inside Philanthropy
Why some family offices are becoming cancer research’s new bankrollers | Crain Currency
π‘ππΎπΊπ ππ©π³π°πΆπ¨π© π’πΊππΌπΎπ’π Tyler Jacks: βWeβve created a new operating model for collaborative cancer research. | The Cancer Letter
BE PART OF THE MISSION
Stay Informed, Make an Impact
Subscribe
Be the first to hear about cutting-edge research, pioneering projects, and the latest advancements in Break Through Cancer science. Sign up to stay informed.
Give
Your contribution fuels groundbreaking research in some of the most challenging cancers. Every gift accelerates progress. For more information please contact Michaela Forand at MF@breakthroughcancer.org or 1-800-757-9881 ext 2.
